Product review · Updated September 30, 2026
La Roche-Posay Effaclar review: the medicated gel has two dated declarations
A July 2025 gel label and a different December 2023 record identify the acne wash more precisely than the Effaclar name alone.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
Effaclar is a range name, not a complete formula. The specific product here is La Roche-Posay’s Effaclar Medicated Cleanser, identified in a July 2025 US labeling record as a salicylic-acid gel. A separately dated December 2023 label uses another product code and a different inactive declaration. The records let the wash be examined without borrowing the identity of a neighboring Effaclar item.
Both official posted labels were read on September 30, 2026. The July record supplies the more recent declaration examined, while the older record makes a version difference visible. The manufacturer product page was unavailable for assessment, so the review does not add an unverified comfort promise. No package, batch assay or comparison of skin outcomes was inspected.
In this article
The medicated cleanser is a particular US gel
The July 2025 label names Effaclar Medicated Cleanser, identifies L’Oreal USA Products Inc and lists salicylic acid 2% with an acne-treatment purpose. Its structured product record calls the preparation a gel and carries NDC 49967-402. These details are more specific than a broad recommendation for the Effaclar brand. July label.
The format guide explains why the product’s role belongs in a comparison. Identifying this wash does not establish that it behaves like a leave-on gel or another salicylic-acid preparation. The matching ingredient name is only part of the description.
The newer inactive list includes sodium benzoate
The July declaration lists the inactive portion as well as the acid active. Among its names are glycerin, decyl glucoside, menthol, zinc gluconate, capryloyl salicylic acid and sodium benzoate. The last of those is a useful marker when the newer narrative is compared with the older label. Complete July declaration.
Naming those constituents establishes their presence in this posted list. It does not quantify each one or explain a particular person’s response. A full declaration gives the product story more substance than a few highlighted ingredients, while still leaving finished-product comfort and actual package identity open. The narrative also names sodium laureth sulfate and coco-betaine. Their inclusion helps identify the full posted wash; the record does not supply an individual quantity for either name or a finished-product measurement of how comfortable this combination feels.
The older label uses another product code
The December 31, 2023 record identifies NDC 49967-023 and also describes a salicylic-acid gel with a 2% active. Its complete inactive narrative contains glycerin, menthol and capryloyl salicylic acid, but differs in sequence from the July 2025 list. Sodium benzoate is not named in that older narrative. December record.
The date and code give the difference a documentary location. They do not prove when every store package changed, whether both packages remain available or why the lists differ. The review keeps the records separate rather than composing a third ingredient list from their shared and unshared names. A label update dates a published document. It does not record an observed manufacturing change in a particular bottle, and a different product code does not explain the cause of every formulation difference. Those additional questions are not answered by matching the active strengths.
Two labels do not make two comfort experiments
The December and July records are distinct dated labeling sets. They support a comparison of product identities and declarations, including the shared active and different inactive narratives. Neither label supplies a consumer assessment of comfort or a head-to-head wash trial. Two informative declarations are therefore not two independent experiments measuring dryness. July record; older label.
A useful adjacent reading is the Neutrogena cream-cleanser review. The comparison concerns how a named wash is documented. It does not make a claim about which wash is gentler, and the available Effaclar labels do not provide such a comparative result.
The dryness warning remains part of the wash record
Both labels warn that irritation and dryness are more likely with another topical acne medicine. That warning belongs beside the active and inactive declarations, even though the product is a cleanser. The presence of glycerin does not remove the warning from the record. Older warnings; July warnings.
The mature, dry-skin guide gives this concern a place in a wider reading discussion. This review does not diagnose dryness or choose a combination of products for anyone. It records the product’s own caution without converting the source directions into a routine.
What this label leaves open about comfort
The examined July record identifies an acne treatment, the gel form, its ingredient declaration and warnings. Those fields help define the product. They do not provide a consumer-perception cohort or a finished-product trial establishing that the wash will avoid tightness or dryness for a particular reader. Examined label.
The Murad cream-cleanser review offers another source story to read alongside this one. A claim documented there should remain attached to that product and its stated assessment. It cannot fill a missing Effaclar result merely because both products are described as acne cleansers.
Label precision leaves a package question open
FDA’s Drug Facts explanation distinguishes an active, therapeutic purpose, warning fields and inactive ingredients. It also explains that manufacturers may change ingredients or labeling and that similar names can identify different products. Those distinctions help interpret the two Effaclar records without treating a posted label as an inspected personal package. FDA label explanation.
The original product comparison provides further format context. Here, the supported conclusion is precise: the newer examined record identifies a 2% medicated gel with its own whole declaration. The older label provides a meaningful version comparison, while product-specific comfort and package matching remain unresolved.
Sources behind this reading
- La Roche-Posay Effaclar Medicated Cleanser: 2023 L’Oreal label ↗Manufacturer-submitted US OTC labeling record · Checked September 30, 2026
- La Roche-Posay Effaclar Medicated Cleanser: July 2025 L’Oreal label ↗Manufacturer-submitted US OTC labeling record · Checked September 30, 2026
- FDA: The Over-the-Counter Drug Facts Label ↗Regulator explanation of OTC label fields · Checked September 30, 2026